Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIKAL. vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    HIKAL. DR. REDDYS LAB HIKAL./
DR. REDDYS LAB
 
P/E (TTM) x 45.5 19.9 229.4% View Chart
P/BV x 2.9 4.5 64.4% View Chart
Dividend Yield % 0.5 0.6 70.3%  

Financials

 HIKAL.   DR. REDDYS LAB
EQUITY SHARE DATA
    HIKAL.
Mar-23
DR. REDDYS LAB
Mar-23
HIKAL./
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs4564,656 9.8%   
Low Rs2163,788 5.7%   
Sales per share (Unadj.) Rs164.11,481.4 11.1%  
Earnings per share (Unadj.) Rs6.4270.7 2.3%  
Cash flow per share (Unadj.) Rs15.2345.7 4.4%  
Dividends per share (Unadj.) Rs1.2040.00 3.0%  
Avg Dividend yield %0.40.9 37.7%  
Book value per share (Unadj.) Rs91.91,389.6 6.6%  
Shares outstanding (eoy) m123.30166.53 74.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.02.8 71.8%   
Avg P/E ratio x52.815.6 338.8%  
P/CF ratio (eoy) x22.112.2 181.0%  
Price / Book Value ratio x3.73.0 120.3%  
Dividend payout %18.914.8 127.7%   
Avg Mkt Cap Rs m41,420703,039 5.9%   
No. of employees `000NANA-   
Total wages/salary Rs m2,22446,466 4.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m20,230246,697 8.2%  
Other income Rs m5410,555 0.5%   
Total revenues Rs m20,284257,252 7.9%   
Gross profit Rs m2,57163,860 4.0%  
Depreciation Rs m1,09012,502 8.7%   
Interest Rs m4811,428 33.7%   
Profit before tax Rs m1,05460,485 1.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m27015,412 1.8%   
Profit after tax Rs m78445,073 1.7%  
Gross profit margin %12.725.9 49.1%  
Effective tax rate %25.625.5 100.5%   
Net profit margin %3.918.3 21.2%  
BALANCE SHEET DATA
Current assets Rs m9,683203,161 4.8%   
Current liabilities Rs m6,90885,721 8.1%   
Net working cap to sales %13.747.6 28.8%  
Current ratio x1.42.4 59.1%  
Inventory Days Days2679 32.3%  
Debtors Days Days80107 74.3%  
Net fixed assets Rs m15,024112,638 13.3%   
Share capital Rs m247833 29.6%   
"Free" reserves Rs m11,088230,571 4.8%   
Net worth Rs m11,335231,404 4.9%   
Long term debt Rs m4,8991,278 383.3%   
Total assets Rs m24,707315,799 7.8%  
Interest coverage x3.243.4 7.4%   
Debt to equity ratio x0.40 7,825.6%  
Sales to assets ratio x0.80.8 104.8%   
Return on assets %5.114.7 34.8%  
Return on equity %6.919.5 35.5%  
Return on capital %9.526.6 35.5%  
Exports to sales %67.652.2 129.6%   
Imports to sales %25.616.8 152.4%   
Exports (fob) Rs m13,684128,803 10.6%   
Imports (cif) Rs m5,18441,484 12.5%   
Fx inflow Rs m13,684128,803 10.6%   
Fx outflow Rs m5,18441,484 12.5%   
Net fx Rs m8,50087,319 9.7%   
CASH FLOW
From Operations Rs m3,15358,875 5.4%  
From Investments Rs m-2,923-41,373 7.1%  
From Financial Activity Rs m-77-26,861 0.3%  
Net Cashflow Rs m153-9,073 -1.7%  

Share Holding

Indian Promoters % 68.9 26.7 258.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.3 47.3 19.6%  
FIIs % 6.1 28.6 21.5%  
ADR/GDR % 0.0 15.3 -  
Free float % 31.2 58.0 53.7%  
Shareholders   74,657 257,794 29.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare HIKAL. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on HIKAL CHEMIC vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

HIKAL CHEMIC vs Dr. Reddys Share Price Performance

Period HIKAL CHEMIC Dr. Reddys S&P BSE HEALTHCARE
1-Day -0.28% 2.50% 1.39%
1-Month -5.55% -3.54% -0.54%
1-Year -1.69% 36.89% 62.16%
3-Year CAGR 22.16% 11.12% 18.24%
5-Year CAGR 9.02% 17.94% 19.84%

* Compound Annual Growth Rate

Here are more details on the HIKAL CHEMIC share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of HIKAL CHEMIC hold a 68.9% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of HIKAL CHEMIC and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, HIKAL CHEMIC paid a dividend of Rs 1.2 per share. This amounted to a Dividend Payout ratio of 18.9%.

Dr. Reddys paid Rs 40.0, and its dividend payout ratio stood at 14.8%.

You may visit here to review the dividend history of HIKAL CHEMIC, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.